Meso
Developing
Active
Analyst sentiment on ISRG
Gaining traction — growing article coverage and momentum.
Score
0.5
Velocity
▲ 0.0
Articles
10
Sources
2
Sentiment Timeline
Event Timeline
Jun 27, 2026
Piper Sandler Highlights Intuitive Surgical (ISRG) on Long-Term Growth Catalysts
Bullish
🤖
AI Overview
What happened: Analyst sentiment on Intuitive Surgical (ISRG) is mixed, with some seeing a strong moat and long-term growth (Piper Sandler, bullish article), while others express concerns about competition (Jim Cramer, bearish article) and maintain sell ratings (Deutsche Bank, bearish article). ISRG stock has declined due to below-consensus forecasts (Brown Advisory, bearish article) but is still favored by some for its strong earnings growth (bullish article).
Market impact: The medical technology sector is affected, with ISRG's stock price fluctuating based on analyst sentiments. Investors are watching ISRG closely due to its dominant position in robotic surgery and potential threats from competitors.
What to watch next: Upcoming catalysts include ISRG's Q2 2023 earnings release (expected on August 2, 2023), which will provide insight into the company's current performance and growth prospects. Additionally, regulatory decisions regarding competitors' robotic surgery systems could impact ISRG's market position.
Market impact: The medical technology sector is affected, with ISRG's stock price fluctuating based on analyst sentiments. Investors are watching ISRG closely due to its dominant position in robotic surgery and potential threats from competitors.
What to watch next: Upcoming catalysts include ISRG's Q2 2023 earnings release (expected on August 2, 2023), which will provide insight into the company's current performance and growth prospects. Additionally, regulatory decisions regarding competitors' robotic surgery systems could impact ISRG's market position.
AI Overview as of Jul 02, 2026
Timeline
Last UpdatedMay 23, 2026